US Patent 11918556 Treatment of circadian rhythm disorders
Patent 11918556 was granted and assigned to Vanda Pharmaceuticals on March, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+28 properties)
Article (+262 characters)
US Patent 11918556 Treatment of circadian rhythm disorders
Article
Patent abstract
Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
John Joseph Feeney0
Louis William Licamele0
Marlene Michelle Dressman0
Mihael H. Polymeropoulos0
Date of Patent
March 5, 2024
0Patent Application Number
176512320
Date Filed
February 15, 2022
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11918556 Treatment of circadian rhythm disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
